Finding better treatments for cognitive challenges in Down syndrome by targeting specific developmental periods.
Strategies for treatment of Down syndrome: Identifying age- and sex-specific developmental windows using inducible genetic reduction of Dyrk1a
This study is looking at ways to help improve thinking skills in people with Down syndrome by finding the best times to treat a specific gene that affects brain development, with the goal of creating better therapies for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10107377 on NIH RePORTER |
What this research studies
This research investigates how to improve cognitive deficits associated with Down syndrome by identifying specific age and sex-related developmental windows for treatment. The approach involves reducing the expression of a gene called Dyrk1a, which is overactive in individuals with Down syndrome, during critical periods of brain development. By focusing on these developmental windows, the research aims to create more effective therapies that can be translated from animal models to human clinical trials. The study emphasizes the importance of considering both age and sex differences in treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Down syndrome, particularly those in specific developmental stages from childhood to adulthood.
Not a fit: Patients without Down syndrome or those who are not in the targeted developmental age ranges may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for cognitive impairments in individuals with Down syndrome, improving their quality of life.
How similar studies have performed: While there have been numerous preclinical studies targeting cognitive deficits in Down syndrome, this approach is innovative and aims to address previously unconsidered factors, making it a novel effort in the field.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Roper, Randall J — Indiana University Indianapolis
- Study coordinator: Roper, Randall J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.